Skip to Main Content
Mental Health & Behavioral Research, Phase I

Safety, feasibility, and tolerability of psilocybin treatment for individuals with functional impairment related to mood, anxiety, trauma and/or addiction symptoms: An open-label proof-of-concept study

What is the purpose of this trial?

This study is testing whether a single dose of psilocybin, a compound found in certain mushrooms, is safe, tolerable, and helpful for adults struggling with symptoms like anxiety, depression, or trauma that interfere with daily life.

Participants will take one dose of psilocybin and attend follow-up visits over six weeks to see if their symptoms improve and how they function day-to-day. The study is open to adults with a wide range of symptoms, even those who don’t have formal diagnosis, and will take place at Yale University in New Haven, CT.

Contact Information

For more information about this study, including how to volunteer, contact Geena Fram

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    12/12/2024
  • Study HIC
    #2000037785
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy